XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Parent Company Only Financial Information
3 Months Ended
Mar. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Parent Company Only Financial Information Parent Company Only Financial Information
Interim Condensed Balance Sheets
March 31
2023
December 31
2022
ASSETS
Cash on deposit at the Bank$10,182 $8,525 
Investments in subsidiaries163,540 158,125 
Premises and equipment1,158 1,171 
Other assets48,058 47,922 
TOTAL ASSETS$222,938 $215,743 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Subordinated debt, net of unamortized issuance costs
$29,267 $29,245 
Other liabilities338 288 
Shareholders' equity193,333 186,210 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$222,938 $215,743 
Interim Condensed Statements of Income
Three Months Ended 
 March 31
20232022
Income
Dividends from subsidiaries$5,000 $800 
Interest income22 
Other income
Total income5,025 807 
Expenses
Interest expense266 266 
Management fee238 225 
Audit, consulting, and legal fees119 120 
Director fees111 106 
Other91 72 
Total expenses825 789 
Income before income tax benefit and equity in undistributed earnings of subsidiaries4,200 18 
Federal income tax benefit168 163 
Income before equity in undistributed earnings of subsidiaries4,368 181 
Undistributed earnings of subsidiaries953 4,553 
Net income$5,321 $4,734 
Interim Condensed Statements of Cash Flows
Three Months Ended 
 March 31
20232022
Operating activities
Net income$5,321 $4,734 
Adjustments to reconcile net income to cash provided by operations
Undistributed earnings of subsidiaries(953)(4,553)
Share-based payment awards under the Directors Plan346 149 
Share-based payment awards under the RSP42 31 
Amortization of subordinated debt issuance costs22 23 
Depreciation13 13 
Changes in operating assets and liabilities which provided (used) cash
Other assets(135)(140)
Other liabilities50 230 
Net cash provided by (used in) operating activities4,706 487 
Investing activities
Financing activities
Cash dividends paid on common stock(2,066)(2,031)
Proceeds from the issuance of common stock462 439 
Common stock repurchased(937)(185)
Common stock purchased for deferred compensation obligations(508)(151)
Net cash provided by (used in) financing activities(3,049)(1,928)
Increase (decrease) in cash and cash equivalents1,657 (1,441)
Cash and cash equivalents at beginning of period8,525 11,535 
Cash and cash equivalents at end of period$10,182 $10,094